Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study
- 31 December 1989
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 10 (4) , 142-150
- https://doi.org/10.1016/0197-2456(89)90053-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- Cancer Statistics, 1988CA: A Cancer Journal for Clinicians, 1988
- Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time bloodThe American Journal of Medicine, 1986
- The 2 × 2 factorial design: Its application to a randomized trial of aspirin and U.S. physiciansStatistics in Medicine, 1985
- Multiple Risk Factor Intervention TrialJAMA, 1982
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- A case-control study of regular aspirin use and coronary deaths.Circulation, 1978
- Aspirin and coronary heart disease: findings of a prospective study.BMJ, 1975